DURHAM, NC, Nov 20, 2008 -- Aldagen today announced positive results from its multicenter Phase 1/2 clinical trial of ALD-301, a novel stem cell therapy being developed for the treatment of critical ...
For plastics manufacturing, petroleum refining, food and biofuel production and numerous other core chemical manufacturing processes, heterogeneous catalysts are crucial. Thermal degradation or ...
We performed integration-site analysis, genetic studies, flow cytometry, and morphologic studies in peripheral-blood and bone marrow samples from patients who received eli-cel therapy in two completed ...
Evaluating the role of ALD coatings in strengthening thermal resilience and longevity in solar long metal tubes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results